Clinical trial
The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis
NCT06463379 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis
- Lead sponsor
- Sohag University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- May 1, 2024
- Completion date
- August 31, 2024
- Enrollment
- 215 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
refractory juvenile idiopathic arthritis (despite 2 dmards still active)